About: Author response to Letter to the Editor ‘Liver impairment associated with disease progression in COVID‐19 patients’

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Author response to Letter to the Editor ‘Liver impairment associated with disease progression in COVID‐19 patients’ Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Author response to Letter to the Editor ‘Liver impairment associated with disease progression in COVID‐19 patients’
Creator	Zhao, Qiu Rci, O Zhang, Yafei Liu, Lan
source	Medline; PMC
abstract	We chose the CAP patients hospitalized in our hospital last year as the control because there was no suitable healthy control group available now. And considering the diverse etiology of CAP, the liver impairment appeared in CAP patients maybe result from ischemia/hypoxia-reperfusion injury, systemic inflammatory response or drug use before hospitalization, besides the pathogen itself.
has issue date	2020-05-13(xsd:dateTime)
bibo:doi	10.1111/liv.14497
bibo:pmid	32348618
has license	no-cc
sha1sum (hex)	db364dc5d0e47e446576ae91ff70d04cac97e805
schema:url	https://doi.org/10.1111/liv.14497
resource representing a document's title	Author response to Letter to the Editor ‘Liver impairment associated with disease progression in COVID‐19 patients’
has PubMed Central identifier	PMC7267612
has PubMed identifier	32348618
schema:publication	Liver Int
resource representing a document's body	covid:db364dc5d0e47e446576ae91ff70d04cac97e805#body_text
is schema:about of	named entity 'Author' named entity 'LETTER' named entity 'Liver impairment' named entity 'COVID-19' named entity 'reperfusion injury' named entity 'glucocorticoids' named entity 'CAP' named entity 'chronic liver disease' named entity 'COVID' named entity 'COVID' named entity 'systemic inflammatory response' named entity 'prognosis' named entity 'aetiology' named entity 'CAP' named entity 'biochemical' named entity 'lymphocytes' named entity 'liver impairment' named entity 'control group' named entity 'systemic inflammatory response' named entity 'CAP' named entity 'liver impairment' named entity 'COVID-19' named entity 'liver impairment' named entity 'liver' named entity 'infection' named entity 'pathogen' named entity 'hypoxia' named entity 'ischaemia' named entity 'NLR' named entity 'CAP' named entity 'inflammatory reaction' named entity 'coronavirus outbreak' named entity 'oral antibiotics' named entity 'liver impairment' named entity 'liver impairment' named entity 'ischaemia' named entity 'community-acquired pneumonia' named entity 'COVID' named entity 'SARS-Cov-2' named entity 'Letter to the Editor' named entity 'disease progression' named entity 'COVID-19' covid:arg/db364dc5d0e47e446576ae91ff70d04cac97e805 named entity 'RESPONSE TO' named entity 'IMPAIRMENT' named entity 'LETTER TO THE EDITOR' named entity 'AUTHOR' named entity 'RESPONSE TO' named entity 'patients' named entity 'Zhou' named entity 'Letter' named entity 'COVID-19' named entity 'progression' named entity 'ZHOU' named entity 'author' named entity 'disease' named entity 'COVID-19' named entity 'Liver' named entity 'response' named entity 'Editor' named entity 'AUTHOR' named entity 'ASSOCIATED WITH' named entity 'DISEASE PROGRESSION' named entity 'PATIENTS' nodeID://b56675634 nodeID://b57133842
is wasQuotedFrom of	covid:arg/db364dc5d0e47e446576ae91ff70d04cac97e805/0
is part of of	Author response to Letter to the Editor ‘Liver impairment associated with disease progression in COVID‐19 patients’ covid:db364dc5d0e47e446576ae91ff70d04cac97e805#body_text We chose the CAP patients hospitalized in our hospital last year as the control because there was no suitable healthy control group available now. And considering the diverse etiology of CAP, the liver impairment appeared in CAP patients maybe result from ischemia/hypoxia-reperfusion injury, systemic inflammatory response or drug use before hospitalization, besides the pathogen itself.

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software